CN117460495A - 具有高载药量中链甘油三酯的稳定液体药物组合物以及与之相关的方法 - Google Patents

具有高载药量中链甘油三酯的稳定液体药物组合物以及与之相关的方法 Download PDF

Info

Publication number
CN117460495A
CN117460495A CN202280037532.5A CN202280037532A CN117460495A CN 117460495 A CN117460495 A CN 117460495A CN 202280037532 A CN202280037532 A CN 202280037532A CN 117460495 A CN117460495 A CN 117460495A
Authority
CN
China
Prior art keywords
pharmaceutical composition
liquid pharmaceutical
emulsion
present disclosure
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280037532.5A
Other languages
English (en)
Chinese (zh)
Inventor
A·J·刘
T·卡斯卡尔德
M·奈尔斯科巴拉辰德兰
S·T·汉德森
B·伯伊德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rising Co
Original Assignee
Rising Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rising Co filed Critical Rising Co
Publication of CN117460495A publication Critical patent/CN117460495A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN202280037532.5A 2021-05-25 2022-05-25 具有高载药量中链甘油三酯的稳定液体药物组合物以及与之相关的方法 Pending CN117460495A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163192826P 2021-05-25 2021-05-25
US63/192,826 2021-05-25
PCT/US2022/030819 WO2022251288A1 (en) 2021-05-25 2022-05-25 Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto

Publications (1)

Publication Number Publication Date
CN117460495A true CN117460495A (zh) 2024-01-26

Family

ID=82115983

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280037532.5A Pending CN117460495A (zh) 2021-05-25 2022-05-25 具有高载药量中链甘油三酯的稳定液体药物组合物以及与之相关的方法

Country Status (10)

Country Link
US (1) US20240238199A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346758A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024519999A (cg-RX-API-DMAC7.html)
KR (1) KR20240012539A (cg-RX-API-DMAC7.html)
CN (1) CN117460495A (cg-RX-API-DMAC7.html)
AU (1) AU2022283278A1 (cg-RX-API-DMAC7.html)
CA (1) CA3220907A1 (cg-RX-API-DMAC7.html)
IL (1) IL308512A (cg-RX-API-DMAC7.html)
WO (1) WO2022251288A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202311798B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024384650A1 (en) * 2023-11-26 2026-07-09 Cerecin Australia Pty Limited Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08505367A (ja) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
ES2553132T3 (es) * 2008-04-22 2015-12-04 Azelis Deutschland Kosmetik Gmbh Utilización de ésteres de ácido cítrico como emulsionantes W/O
BR112016018673B1 (pt) * 2014-02-14 2023-10-17 Jingjun Huang Composição em nanoemulsão de óleo em água estável opticamente clara, método de produção da mesma, e, formulação de carreador
EA201992178A1 (ru) * 2017-03-15 2020-05-22 Сересин Инк. Фармацевтические композиции с высоким содержанием лекарственного средства из среднецепочечных триглицеридов и способы, связанные c ними
EP3934630A4 (en) * 2019-03-04 2022-11-23 Cerecin Inc. MEDIUM CHAIN TRIGLYCERIDE FORMULATIONS WITH IMPROVED BIOAVAILABILITY AND RELATED METHODS
US11857931B2 (en) * 2020-01-07 2024-01-02 WAKAMONO joint stock company Process for production of nano-microemulsion system of plant oil triglycerides

Also Published As

Publication number Publication date
AU2022283278A1 (en) 2024-01-18
ZA202311798B (en) 2025-04-30
JP2024519999A (ja) 2024-05-21
WO2022251288A1 (en) 2022-12-01
EP4346758A1 (en) 2024-04-10
KR20240012539A (ko) 2024-01-29
US20240238199A1 (en) 2024-07-18
IL308512A (en) 2024-01-01
CA3220907A1 (en) 2022-12-01

Similar Documents

Publication Publication Date Title
JP7573541B2 (ja) バイオアベイラビリティが改善した中鎖脂肪酸トリグリセリド製剤およびそれに関連する方法
CN115364052B (zh) 具有高载药量的中链甘油三酯的药物组合物及其相关方法
WO2016117621A1 (ja) ω3脂肪酸の自己乳化組成物
JP2021526510A (ja) Gpcを含有する非経口栄養のための脂質エマルション
JP2020530464A (ja) 魚油および/またはオメガ3脂肪酸を含むエマルジョンに関する方法および組成物
BRPI0407338B1 (pt) nutriente dietético ou suplemento alimentar compreendendo uma composição comestível, bem como uma composição farmacêutica oralmente administrável e respectivos usos
US20240238199A1 (en) Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
JP7861248B2 (ja) 制御された薬物動態、安全性および忍容性プロファイルを有する中鎖トリグリセリドを送達するための方法
HK40077205B (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
HK40119699A (en) Medium chain triglyceride formulations with improved bioavailability and methods related thereto
HK40077205A (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
HK40062099A (en) Medium chain triglyceride formulations with improved bioavailability and methods related thereto
BR112019019098B1 (pt) Composição farmacêutica em pó seca por pulverização tendo alto carregamento de fármaco de triglicerídeos de cadeia média e seu método de produção
HK40096010A (en) Methods for delivering medium chain triglycerides with controlled pharmacokinetic, safety and tolerability profiles
WO2025114471A1 (en) Diamine oxidase (dao) for use in the treatment and/or prevention of dry eye disease
BR112020002638B1 (pt) Métodos e composições relativas a emulsões compreendendo óleo de peixe e/ou ácidos graxos ômega-3

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination